The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development project spearheaded by MIT.

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

Biogen (NASDAQ:BIIB) said on Wednesday that the U.S. FDA has granted Fast Track designation to BIIB080, its antisense ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...

Biogen has unveiled plans to open a new global headquarters and innovation hub in Massachusetts, US. The company has signed a 15-year lease for an office and research and development (R&D) space at ...

Biogen has announced plans to establish a new global headquarters and innovation hub in Cambridge, Mass., which will integrate its research and development, technical operations, and commercial teams ...

March 24, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced plans for its new global headquarters at Kendall Common, located at 75 Broadway in Cambridge, as part of a multi-year real ...